Related Experiment Video
Updated: May 8, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
[Pharmacotherapy of patients with mild hypertension in primary care]
Maja Skov Paulsen1, Bo Christensen, Jens Søndergaard
1Forskningsenheden for Almen Praksis i Odense, Institut for Sundhedstjenesteforskning, Syddansk Universitet, J.B. Winsløws Vej 9A, 5000 Odense C. mspaulsen@health.sdu.dk
Insights
Pharmacotherapy for mild hypertension does not reduce mortality or morbidity, despite current guidelines. Evidence supporting drug treatment for uncomplicated hypertension is weak.
Area of Science:
- Cardiology
- Clinical Pharmacy
- Public Health
Context:
- Hypertension is a significant risk factor for cardiovascular disease.
- Primary care in Denmark manages most hypertension patients.
- Current Danish guidelines recommend pharmacotherapy for mild/uncomplicated hypertension.
Purpose:
- To evaluate the evidence for pharmacotherapy in mild hypertension.
- To assess the impact of pharmacotherapy on mortality and morbidity in mild hypertension patients.
- To inform clinical practice and guideline development regarding mild hypertension management.
Summary:
- A Cochrane review found no reduction in mortality or morbidity with pharmacotherapy for mild hypertension (systolic 140-159 mmHg, diastolic 90-99 mmHg, no comorbidities).
- The evidence supporting drug treatment for mild, uncomplicated hypertension is considered weak.
- Despite weak evidence, Danish guidelines currently recommend pharmacotherapy for these patients.
Impact:
- Highlights a potential discrepancy between evidence and current clinical guidelines for mild hypertension.
- Suggests a need for re-evaluation of pharmacotherapy recommendations in primary care for mild hypertension.
- Emphasizes the importance of evidence-based practice in managing cardiovascular risk factors.
Abstract:
Hypertension is an important risk factor for cardiovascular disease. In Denmark, patients with hypertension are primarily managed in primary care. A recent Cochrane review concluded that pharmacotherapy of patients with mild hypertension (systolic blood pressure 140-159 mmHg; diastolic blood pressure 90-99 mmHg; no diabetes or cardiovascular disease) did not reduce mortality or morbidity. The evidence for pharmacotherapy in patients having mild/uncomplicated hypertension is weak. However, current Danish guidelines have taken this into consideration in their recommendations of pharmacotherapy to patients with mild/uncomplicated hypertension.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Antihypertensive Drugs: Action of Diuretics